Jim Cramer says IBM’s stock is a ‘trust but verify’ situation

Jim Cramer says IBM’s stock is a ‘trust but verify’ situation


CNBC’s Jim Cramer on Thursday advised investors to tread carefully if they’re debating whether to buy shares of IBM after the company reported its third quarter earnings.

“Even after IBM’s nearly 5% rally today, the stock’s still down substantially versus where it was trading just a few months ago. I’m optimistic … but keep in mind this remains a ‘trust but verify’ situation going forward,” he said.

IBM beat revenue and earnings estimates in its third-quarter results reported on Wednesday and raised its revenue outlook. The enterprise software and consulting company said that revenue increased 6.5% year-over-year.

While the strong U.S. dollar is a headwind for the company, which expects that it will have 7% less full-year revenue than it otherwise would have made, IBM still reiterated its guidance from earlier this year of around $10 billion in free cash flow.

“Put it all together and while IBM still has plenty of room for improvement, this quarter was a big step forward for them and it was a major win for the bulls,” Cramer said.

He added that the company’s spin-off of its managed infrastructure services business into Kyndryl in November 2021 seems to be paying off.

“Remember, IBM went through that whole Kyndryl spin off in order to become a growth company again, and that’s now what they are — they’ve got growth in spades,”  he said.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

FDA fast-tracks psychedelic drug research following Trump executive order
Business

FDA fast-tracks psychedelic drug research following Trump executive order

FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. DEA | Reuters The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. That […]

Read More
New York’s pied-a-terre tax sets up legal fight over values
Business

New York’s pied-a-terre tax sets up legal fight over values

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. New York’s proposed tax on second homes worth more than $5 million is likely to spark costly legal battles over how to value […]

Read More
Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More